1. 1251-labelled (Asn1,Va15)-angiotensin I1 (1251-labelled AII) incubated with purified rat liver membranes was degraded with time, as estimated by three techniques: binding to an excess of specific antibody, polyacrylamide-gel electrophoresis and rebinding to fresh membranes. Degradation was inhibited in the presence of an excess of corticotrophin but still very marked.
Introduction
Angiotensin I1 (AII) binds to multiple target cells as the first step of its physiological effects in aorta smooth muscle (Baudoin, Meyer & Worcel, 1971) , adrenals (Glossmann, Baukal & Catt, 1974) , uterine smooth muscle (Rouzaire-Dubois, Dewynck, Chevillotte & Meyer, 1975), brain (Bennet & Snyder, 1976) and renal glomeruli (Sraer, Sraer, Ardaillou & Mimoune, 1974) . The liver seems to be a target tissue for A11 since this hormone has been demonstrated to increase both the production of the plasma renin substrate (Khayyall, MacGregor, Brown, Lever & Robertson, 1973) and the activity of glycogen phosphorylase (Keppens & De Wulf, 1976) . The liver is also the main site of catabolism for AII, as shown by Mathot, Meyer, Biron, Lorain, Lagrue & Milliez (1964) , Johnson & Ryan (1968) and Leary & Ledingham (1970) . This led us to look for specific binding sites for A11 in hepatic membranes and to study the relationship between these sites and the degradation of AII.
Methods

Materials
(Asnl,Vals)-AII (donated by Ciba-Geigy, Basel, Switzerland) was labelled with lZsI by the method of Hunter & Greenwood (1962) . Labelled and unlabelled molecules were separated by using polyacrylamide-gel electrophoresis according to Corvol, Rodbard, Drouet, Catt & Menard (1973) . The specific radioactivity of the labelled hormone assessed by radioimmunoassay was 2000 Ci/mmol. This is close to the theoretical value corresponding to 1 atom of iodine/molecule. (Asp', Ile5)-A11 and (Des, Asp', Ile5)-A11 were purchased from Beckman (Geneva, Switzerland) and the hexa-and penta-peptides derived from (Asp', Ile5)-AII were purchased from SchwarzMann (Orangeburg, N.Y., U.S.A.). Corticotrophin (Synacthen) was donated by CibaGeigy. Chemicals were analytical grade reagents.
Preparation of liver membranes
Male Sprague-Dawley rats (150-220 g) were fed ad libitum and killed by decapitation. Purified rat liver membranes were then prepared according to Ray (1969) and kept at -2OOC in NaHCO, solution (1 mmol/l). Their concentration was estimated by measuring the protein concentration according to Lowry, Rosebrough, Farr & Randall (1951) . 5'-Nucleotidase (EC 3.1.3.5) and glucose 6-phosphatase (EC 3.1.3.9) activities were assayed according to Ray (1969) and expressed on a protein weight basis. The values obtained (50-70 pmol h-' mg-1 of protein for 5'-nucleotidase and 2-5 pmol h-' mg-' of protein for glucose 6-phosphatase) were in the range of those reported in the literature (Coleman, Michell, Finean & Hawthorne, 1967; Emmelot, Bos, Benedetti & Rumke, 1964) , thus showing the validity of the purification process.
Binding studies
The incubation medium initially consisted of 200 p1 of Tris/HCl (20 mmol/l), pH 7.5, containing NaCl (135 mmol/l), sodium acetate (10 mmol/l), KCl (10 mmol/l) and glucose (5 mmol/l). Bovine serum albumin and corticotrophin (Synacthen, Ciba-Geigy) were added at final concentrations of 20 mg/ml and 45 pmol/l respectively. The latter product was included in most experiments to partly inhibit degradation of the tracer (Sraer et al., 1974) . Incubation was performed at 20-22OC in the presence of '2SI-labelled A11 (70 pmol/l) and 30 pg of membrane protein/ml under continuous agitation. At the end of the incubation, bound radioactivity was separated by filtration through a Millipore filter (HAWP 02500) with 0.45 pm diameter pores. In some cases, however, the amount of degraded hormone bound was estimated and molar terms were used.
Binding was studied in the presence of several drugs known to be angiotensinase inhibitors (Boyd & Peart, 1974; Delorme, Phan Tam Guyene, Corvol & Menard, 1976) : phenylmethylsulphonylfluoride; 2,3-dimercaptopropan-1-01 (BAL); 8-hydroxyquinoline; disodium salt ethylenediaminotetra-acetic acid (EDTA); corticotrophin, which competes for the catalytic site of non-specific peptidases. In order to separate the effects of these drugs on the receptor itself from those on the binding process, two parallel studies were performed. The drug was either preincubated for 30 min with membranes in the absence of '251-labelled AII, which was subsequently added after washing, or added directly to the incubation medium. In both cases, binding was measured after 30 and 60 min incubation.
Degradation studies
Degradation of '251-labelled A11 present in the incubation medium was studied by three techniques: binding to an excess of specific antibodies, polyacrylamide-gel electrophoresis and rebinding to fresh membranes. Polyacrylamide-gel electrophoresis was performed according to Corvol et al. (1973) . Operating pH of the lower gel was 10.2 at OOC. Stacking gel and separation gel were made at 3.125% T, 20% C and 10% C respectively (% T = total gel concentration; % C = percentage crosslinking). Undamaged hormone was estimated as the peak of radioactivity corresponding to the R, of 1251-labelled AII. Binding of '251-labelled A11 to an excess of specific antibody was measured after 16 h incubation. This antibody had been raised in the rabbit after administration of (Asn',ValS)-A11 and was used at a final dilution of 1 :400, at which more than 90% of the total radioactivity was bound. It could not distinguish between A11 and (Des, Asp', Ile5)-AII and partly cross-reacted with the hexa-and the penta-peptide. The percentage of cross-reaction was estimated according to Abraham (1969) . The values obtained were 50 and 12.5% for the hexa-and the penta-peptide respectively. Free and bound radioactivity were separated by using Dextran-coated charcoal. Rebinding to fresh membranes required a second incubation in conditions similar to those of the first one, binding being measured after 100 min incubation. In each experiment, appropriate control systems were prepared in which conditions were identical except that hepatic membranes were omitted.
Bound hormone was eluted by incubation of the membrane pellet in 500 p1 of acetic acid (10 mmol/l) at 22OC for 30 min. The eluate was then neutralized by addition of NaOH solution (0-1 mol/l) and the eluted hormone examined by two techniques: polyacrylamide-gel electrophoresis and binding to an excess of specific antibody. The amount of lZSI-labelled A11 eluted was not sufficient to allow the use of the rebinding technique.
Results
Degradation studies
1251-labelled A11 present in the incubation medium was progressively degraded with time at 22OC (Fig. 1) . After 120 min incubation, the amount of undegraded hormone left was clearly diminished: 22, 46 and 75% as estimated by rebinding to fresh membranes, by polyacrylamide-gel electrophoresis and by binding to an excess of anti-A11 antibody respectively. The first of these techniques, which gave the lowest results, can be considered as the most specific. Degradation was still present at 8OC but less marked: 63, 80 and 85% of undegraded hormone as estimated by the three same techniques respectively persisted after 120 min incubation. Degradation still progressed from 120 to 360 min, as shown in Fig. 1 . Bound hormone was also partly degraded. Degradation was less clearly dependent of time and was marked from the beginning of the incubation. After 30 min incubation at 22OC, there was only 60 and 62%
Polyacrylamide-gel electrophoresis
Binding to an excess of antibody Rebinding to fresh membrane -0 60 120 180 240300 360 
Binding studies
Because of the marked degradation of 1251-labelled A11 when no angiotensinase inhibitor was added, the following experiments were performed in the presence of corticotrophin (45 ,umol/l). The time-course of 12SI-labelled A11 binding was studied at two concentrations of '2SI-labelled A11 (Fig. 2) . In both cases, equilibrium was reached after 80 min incubation. Addition of unlabelled A11 produced some dissociation of the bound hormone but, as shown in Fig. 2 , the rate of dissociation was very slow and a complete dissociation could not be obtained during the time of the study. The dissociation constant (k-,) calculated from six different experiments was 0.0032 ? 0.0011 min-' (mean SEM). Binding at equilibrium increased as T a function of 1251-labelled A11 concentration in the incubation medium and reached a plateau at 1.5 nmol/l. Concentration corresponding to 50% of this plateau was 0.28 nmol/l (Fig. 3a) . The data were transformed according to Scatchard after correction for degradation. Undegraded bound and free hormone were estimated by polyacrylamidegel electrophoresis. A straight line was obtained, allowing calculation of the number of binding sites (617 fmol/mg of membrane protein) and the apparent dissociation constant K, (0.198 nmol/l) .
'251-labelled A11 binding was progressively inhibited by increasing concentrations of unlabelled AIL 50% inhibition was obtained at 0.5 nmol/l (Fig. 4a) . The data of this experiment were also analysed according to Scatchard after correction for degradation of bound and free A11 at equilibrium. The regression line obtained allowed calculation of K , (0.173 nmol/l) and number of sites (516 fmol/mg of membrane protein) (Fig. 4b) . Analogues and peptides derived from A11 by progressive deletion of the N-terminal part of the molecule were tested for their potency of inhibition of '251-labelled A11 binding with doses ranging from 1 pmol/l up to 10 ,umol/l. The percentage crossreaction was estimated as stated above for anti-A11 antibody. (Asp', IleS)-A11 was equally active (loo%), whereas its derived heptapeptide was slightly less potent (67%). The hexa-and pentapeptide competed with '2SI-labelled A11 binding led to different results depending on the inhibitor studied. Binding was clearly increased in the presence of phenylmethylsulphonylfluoride (0.1 mmol/l) or of corticotrophin (45 ,umol/l), chiefly after 60 min incubation, whereas it was slightly diminished when BAL (4.8 mmol/l) was added and markedly decreased or even suppressed with 8-hydroxyquinoline (4.1 mmol/l) and disodium EDTA (10 mmol/l) respectively. On the contrary, preincubation of hepatic membranes with each of these drugs did not noticeably modify the subsequent binding of 12SI-labelled A11 (Fig. 5) .
Discussion
The three techniques used to test degradation of 1251-labelled A11 present in the incubation medium gave results which were qualitatively similar but quantitatively different. This was because the techniques are based on different physical principles. Binding to an excess of specific antibody clearly depends on the specificity of the antibody used. In the present experiments, the anti-A11 antibody did not distinguish the heptapeptide and cross-reacted partly with the hexa-and the pentapeptide. Polyacrylamide-gel electrophoresis was performed at only one acrylamide concentration and one operative pH. In this condition, one cannot exclude the possibility of coincident peaks corresponding to peptides with similar electric charges. However, we have shown in unpublished data that the R, of 1251-labelled (Aspl,IleS)-A11 and of 1251-labelled (Des,Asp1,11e5)-AII were markedly different: 0.90 and 0.47 respectively. This technique thus allows separation of these two peptides, which differ by one amino acid residue. We were unable to perform the parallel experiment with 1251-labelled (Asn1,Va15)-AII, which was used in the present study, since the corresponding heptapeptide was not available. Similarly, Corvol et al. (1973) observed that 12SI-labelled angiotensin peptides differing in two amino acid residues migrated in the same system at clearly different R, values. Rebinding to fresh membranes measures the fraction of radioactive hormone which specifically rebinds and thus keeps its biological activity. This does not necessarily correspond to intact hormone, particularly in the case of AII, since the heptapeptide binds to the hepatic receptors, but this technique readily distinguishes the peptides obtained after further degradation as shown in the present results. The rebinding technique is thus the most satisfactory since it separates molecules which specifically bind from those unable to interact with the receptors. Binding of 1251-labelled A11 to hepatic membranes displays some of the conditions required to demonstrate specificity of binding. Binding occurred at low concentrations of AII. The apparent K , of approximately 0.1 nmol/l is slightly greater than the plasma A11 concentration in the rat (PowellJackson & MacGregor, 1976) . 1251-labelled A11 binding reached a plateau with increasing incubation times and/or increasing 12sI-labelled A11 concentrations. Addition of an excess of unlabelled A11 at equilibrium produced release of the labelled hormone from its binding sites. Binding was competitively inhibited by unlabelled hormone and analogues, in contrast with the lesser effect observed in the presence of shorter peptides known to be devoid of biological activity (hexa-and pentapeptide). However, some of the characteristics of 1251-labelled A11 binding are not in favour of specificity. Association and dissociation rates were very slow in contrast to the well-known rapidity of action of this hormone. Dissociation was incom-plete and never reached the level of non-specific binding. Bound hormone was partly degraded as early as 30 min after the beginning of the incubation. Degradation of lz5I-labelled A11 present in the incubation medium was also marked and increased progressively with time, making it dimcult to interpret binding kinetics and to calculate the indices of binding. Finally, no correlation was established between Iz5I-labelled A11 binding and a biological effect of A11 on liver function. Calculation of the indices of binding was performed only by using the results at equilibrium, since correction for degraded hormone had to be made at one time only. Scatchard's plot analyses of data obtained both from binding at equilibrium and competitive inhibition studies showed only one straight line. This demonstrates that the highaffinity binding sites for intact A11 are homogeneous.
The nature of the binding sites studied in the present report is probably complex. Preincubation of hepatic membranes with angiotensinase inhibitors did not suppress the binding. Therefore it is possible to conclude that these binding sites do not correspond entirely to the catalytic unit of membrane angiotensinases. The same problem has arisen in the interpretation of 3H-labelled catecholamine binding and has been discussed extensively. For example, Cuatrecasas, Tell, Sica, Parikh & Chang (1974) proposed that these binding sites were related to the membrane-bound form of the metabolizing enzyme, catechol-0-methyltransferase. This contention was rejected by several laboratories for several reasons, one of which was the absence of inhibition of binding in the presence of potent catechol-0-methyltransferase inhibitors (Lefkowitz, 1974) . Another hypothesis was that "-labelled catecholamine binding was related to an oxidative process destroying the catecholamine (Maguire, Goldman & Gilman, 1974) . In the case of 1Z51-labelled A11 and hepatic membranes, binding was clearly increased in the presence of corticotrophin and/or phenylmethylsulphonylfluoride. This shows that degrading enzymes and binding sites are distinct units. Inhibition of the enzymes makes more angiotensin I1 available and thus facilitates binding.
In conclusion, it seems likely that lZ51-labelled A11 binding to hepatic membranes delineates a heterogeneous group of sites. The high-affinity binding sites probably correspond to true receptors or other membrane-bound 'acceptor' sites. The degrading enzymes are likely to be associated with lower-affinity binding sites. Their study would 4 require experiments at higher concentrations of AII. The respective roles of these various binding sites in the metabolism of angiotensin I1 by the liver or the action of angiotensin I1 on the liver are at present unclear.
